Aethon Therapeutics

Developer of immunotherapies for cancer treatment

placeNew York City, New York, United States calendar_todayFounded 2022 groups7 employees language aethontx.com

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 5 times.

YearFilings
20252
20261

Social engagement

Social engagement: 3K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

21 Apr 2026
Event
AACR2026
Coming soon